Genito-Urinary Drugs Market Global Briefing 2022: Ukraine-Russia War Impact

Sep 2022| MKB182H| TBRC (Publisher)

Report Highlights

Including: Hormonal Contraceptives; Drugs For Benign Prostatic hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Diuretics

Global genito-urinary drugs market was worth $40.3 billion in 2021, it was the eleventh largest segment within the market accounting for 2.7%. In terms of per capita consumption, the market was $5.2 and in terms of global GDP, the market was 0.04%. Genito-urinary drugs was the eleventh largest segment within the market accounting for 2.7% preceded and followed by dermatology drugs at 3.4% and hematology drugs at 2.2% respectively.

Genito-Urinary Drugs Market Global Briefing 2022: Ukraine-Russia War Impact provides strategists, marketers and senior management with the critical information they need to assess the global genito-urinary drugs sector.

Reasons to Purchase

  • Fully updated for 2022 with Ukraine-Russia War Impact.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.

Description

Genito-Urinary Drugs Market Global Briefing 2022: Ukraine-Russia War Impact from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, trends and strategies for this market.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the genito-urinary drugs market revenues, covering both the historic growth of the market and forecasting the future.
  • Market segmentations break down the key sub sectors which make up the market.
  • The regional breakdowns section gives the size of the market geographically.
  • The trends and strategies section highlights the likely future developments in the genito-urinary drugs market and suggests approaches.

 

 

Scope

Markets Covered: Hormonal Contraceptives; Drugs For Benign Prostatic hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Diuretics

Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa

Time series: Five years historic and forecast

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Genito-Urinary Drugs Market, Historic Market Size, 2016-2021, $
  • Table 2 : Global Genito-Urinary Drugs Market, Forecast Market Size, 2021-2026, $
  • Table 3 : Global Genito-Urinary Drugs Market, Split By Segment, 2021, $
  • Table 4 : Global Genito-Urinary Drugs Market, Historic And Forecast, Split By Segment, 2016-2026
  • Table 5 : Global Genito-Urinary Drugs Market, Split By Region, 2021, $
  • Table 6 : Global Genito-Urinary Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2016-2026
  • Table 7 : Genito-Urinary Drugs Market Data Sources
  • Figure 1 : Global Genito-Urinary Drugs Market, Historic Market Size, 2016-2021, $
  • Figure 2 : Global Genito-Urinary Drugs Market, Forecast Market Size, 2021-2026, $
  • Figure 3 : Global Genito-Urinary Drugs Market, Split By Segment, 2021, $
  • Figure 4 : Global Genito-Urinary Drugs Market, Historic And Forecast, Split By Segment, 2016-2026
  • Figure 5 : Global Genito-Urinary Drugs Market, Split By Region, 2021, $
  • Figure 6 : Global Genito-Urinary Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2016-2026

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Genito-Urinary Drugs Global Market Competitor Briefing 2021

  • Date - Dec 2021
  • Code - MKB182G

Including: Hormonal Contraceptives; Drugs For Hormonal Replacement Therapy; Drugs For Benign Prostatic hypertrophy; Drugs For Erectile Dysfunction; Drugs For Infertility
Covering: Sanofi S.A; GlaxosmithKline; AstraZeneca; AbbVie; Reckitt Benckiser Group plc

Sanofi S.A was the largest competitor with 12.00% of the market followed by GlaxosmithKline with 5.95%, and AstraZeneca and AbbVie

Genito-Urinary Drugs Global Market Competitor Briefing 2021 provides strategists, marketers ...

Genito-Urinary Drugs Investment Competitor Outlook 2020: Covid 19 Impact and Recovery

  • Date - Nov 2020
  • Code - MKB182F

Including: Hormonal Contraceptives; Drugs For Hormonal Replacement Therapy; Drugs For Benign Prostatic hypertrophy; Drugs For Erectile Dysfunction; Drugs For Infertility; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Diuretics

Covering: Sanofi S.A; Bayer AG; Pfizer Inc.; AstraZeneca; Reckitt Benckiser Group plc

Sanofi S.A was the largest competitor with 19.28% of the market followed by Bayer AG ...

Genito-Urinary Drugs Market Global Briefing 2020: Covid 19 Impact and Recovery

  • Date - Apr 2020
  • Code - MKB182E

Including: Hormonal Contraceptives; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Drugs For Erectile Dysfunction; Drugs For Benign Prostatic hypertrophy; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infertility; Diuretics

Genito-Urinary Drugs Market Competitor Briefing 2019

  • Date - Nov 2019
  • Code - MKB182D

Including: Hormonal Contraceptives; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Drugs For Erectile Dysfunction; Drugs For Benign Prostatic hypertrophy; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infertility; Diuretics

Covering: Pfizer; Bayer AG; Novartis AG; Allergan Plc.; AbbVie

Research Methodology
The report is built on information collected through secondary sources and analysis done by ...

Genito-Urinary Drugs Market Global Briefing 2019

  • Date - May 2019
  • Code - MKB182C

Research Methodology

The report is built on information collected through secondary sources and analysis done by The Business Research Company (TBRC). The secondary sources include the data published by statistical bodies, government agencies, market intelligence databases and annual reports. Insights on the current market scenario, historic and forecast market drivers were gathered from industry reports and news articles.

Note on ...

Genito-Urinary Drugs Market Global Briefing 2018

  • Date - Jan 2018
  • Code - MKB182B

Including: Diuretics, Hormonal Contraceptives, Drugs For Hormonal Replacement Therapy, Infections, Benign Prostatic Hypertrophy, Erectile Dysfunction, Urinary Incontinence And Overactive Bladder, Infertility

Covering: Daiichi Sankyo Company, Limited, Pfizer Inc., Bayer AG, Astellas Pharma Inc., Allergan Plc., Otsuka Pharmaceutical Co., Ltd., GlaxosmithKline Plc., Sanofi S.A.

Research Methodology

The Business Research Company’s reports are based on the methodology below.

Data –

Our datasets ...

Genito urinary Drugs Market Global Briefing 2017

  • Date - Jul 2017
  • Code - MKB182A

Including: Hormonal contraceptives, Drugs For Hormonal Replacement Therapy, Drugs For Infections And Others, Drugs for Benign prostatic hypertrophy, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs for Infertility, and Diuretics

Covering: Daiichi Sankyo Company, Limited, Pfizer Inc., Bayer AG, Astellas Pharma Inc., Allergan Plc., Otsuka Pharmaceutical Co., Ltd., GlaxosmithKline Plc., Sanofi S.A

Research Methodology

The Business ...

The Business Research Company
Price: $2500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS